Next Article in Journal
Effects of Co-Addition of Copper, Sodium and Ethylammonium to CH3NH3PbI3 Perovskite Compound
Previous Article in Journal
Synthesis of N-(hydroxymethylene)thioamides by N-hydroxymethylation of 2-cyanothioacrylamides
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Proceeding Paper

Structural Study of a Pd–Fe Hetero-Trinuclear Compound †

by
Paula Munín-Cruz
*,
Marcos Rúa-Sueiro
,
Juan M. Ortigueira
,
María Teresa Pereira
and
José M. Vila
Department of Inorganic Chemistry, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain
*
Author to whom correspondence should be addressed.
Presented at the 3rd International Online Conference on Crystals, 15–30 January 2022; Available online: https://iocc_2022.sciforum.net/.
Chem. Proc. 2022, 9(1), 5; https://doi.org/10.3390/IOCC_2022-12145
Published: 12 January 2022
(This article belongs to the Proceedings of The 3rd International Online Conference on Crystals)

Abstract

:
Cyclometallated compounds, specifically cyclopalladates, have been synthesized for years. In this work, we describe a new family of compounds in which an iron core has been introduced in addition to Pd. This novel characteristic provides interesting properties to these compounds, such as the possibility of undergoing reduction–oxidation processes due to the versatility of the iron nucleus. An XRD study of the resulting crystalline structure allows explaining the compound behavior.

1. Introduction

Thiosemicarbazones are a type of ligands obtained by condensation of the carbonyl group of an aldehyde or ketone and the amino group of a thiosemicarbazide, as is shown in Figure 1.
These types of compounds are well-known antibacterial or antifungal agents: for example, studies for the treatment of tuberculosis were carried out in the 1950s. Nowadays, studies are more focused on the synthesis of new derivatives for their use as antitumorals [1].
This work presents the synthesis and study of thiosemicarbazone family derivatives with two methoxy substituents as can be seen in Figure 2.

2. Materials and Methods

2.1. Ligand Synthesis Procedure

The appropriate amount of thiosemicarbazide (5.50 mmol) was dissolved in 40 cm3 of distilled water and a small amount of hydrochloric acid (0.50 cm3) in a 100 mL round-bottom flask. The addition of hydrochloric acid does not only enable solubilization but also favors the condensation reaction (Figure 3). Once the thiosemicarbazide had been completely solubilized, the corresponding ketone (1 Eq, 5.50 mmol, see Table 1) was added and the mixture stirred at room temperature for 8 h.
In all cases, an off-white solid that could be separated by filtration appeared. This solid was thoroughly washed with water and then dried under vacuum to afford the pure thiosemicarbazone.

2.2. Syntheis of Palladium Organometallic Compounds

In a 100 mL round-bottom flask, 200 mg (0.61 mmol) of potassium tetrachloropalladate was dissolved in 6 cm3 of distilled water and 40 cm3 of ethanol. The corresponding amount of ligand (1.1 Eq, 0.67 mmol, see Table 2) was added after a yellow suspension appeared, and the resulting mixture was stirred at room temperature for 24 h.
In each case, the reaction product was obtained as a fine solid in suspension, which was separated by centrifugation, decantated, and vacuum-dried to afford the pure compound (Figure 4). Said solids, regardless of R2, have varied colors, ranging from yellow to orange.

2.3. Synthesis of Pd–Fe Hetero-Trimetallic Compounds

For the synthesis of the compounds bearing 1,1′-bis(diphenylphosphino)ferrocene (dppf), a suspension of the corresponding cyclometallated compound (20 mg) in 10 cm3 of acetone was prepared in a Radleys tube, to which the appropriate quantity of phosphine (4 Eq, see Table 3) was added. The mixture was stirred at 50 °C for 24 h. The resulting products appeared as orange solids that could be filtered off, washed with the minimum amount of hexanes, and dried under vacuum.
Due to the stoichiometry of the reaction, derivatives in which the diphosphine moiety acts as a monodentate ligand would be expected, as is shown in Figure 5. However, in all cases, the results show greater preference for bidentate bridge coordination through said phosphine (Figure 6).
The addition of an iron nucleus to these compounds provides the possibility for them to be used for reduction–oxidation processes increasing their properties in the electrochemical field [2].

3. Results and Discussion

The structural characterization of the compounds was carried out using proton nuclear magnetic resonance. Furthermore, in the case of Pd–Fe organometallic compounds, phosphorous nuclear magnetic resonance (31P-{1H}-NMR) was required, since it provides additional information on the behavior of the phosphine.

3.1. H and 31P-{1H}-NMR Spectroscopy Study

3.1.1. H-NMR for Ligands (14)

In all cases, the spectra of these ligands show two doublets corresponding to the H2 and H5 protons and one doublet of doublets for the H6 proton. The rest of the signals are also consistent with what would be expected for the proposed structures (Figure 7).
The data extracted from the proton nuclear magnetic resonance spectra of the ligands 14 are shown in Table 4.

3.1.2. H-NMR for Palladium Organometallic Compounds (58)

As metallation of the carbon of the aromatic ring occurs, the complexity of the signals observed in the magnetic resonance spectra is reduced: two singlets are registered in the aromatic zone and the signal that can be observed at lower field is the one corresponding to the H5 proton (Figure 8).
The data obtained from the proton magnetic resonance spectra for palladium organometallic compounds 58 are shown in Table 5.

3.1.3. H-NMR and 31P-{1H}-NMR for Pd–Fe Organometallic Compounds (912)

The signal appearing at the lower field is, in all cases, a singlet that corresponds to the H2 proton. When the coordination of the phosphorus nucleus occurs, the signal of proton H5 appears as a doublet because it is coupled with this nucleus. This signal (H5) and the one corresponding to the methoxy group at position four are shifted towards the high field with respect to the compound from which they derive (vide supra). This effect can be justified with the structural data obtained after crystal structure resolution of the compound.
The signals corresponding to the coordinated phosphine are observed in two zones: the protons of the phenyl rings appear in the aromatic zone, between 7.3 and 7.6 ppm, and the protons of the cyclopentadienyl rings appear between 4.2 and 5.1 ppm. The protons located in ortho with respect to the phosphorus atom are those appearing at the lower field (Figure 9).
Analysis of the phosphorus NMR spectra indicates that both nuclei are equivalent since a single singlet signal can be observed; in addition, the position in which they appear, ca. 29 ppm, shifted to the low field with respect to the position where the free phosphine signal appears (−18.8 ppm), indicating that they are coordinated to the metal center (Figure 10).
This fact, together with the presence of a single signal for the different groups of the dinuclear compound in the proton NMR spectra, indicates that the compounds are symmetric in solution.
The data inferred from the signals of the proton and phosphorus NMR spectra of the Pd–Fe organometallic compounds 912 are shown in Table 6.

3.2. X-ray Spectroscopy Discussion for Compound 10

Crystals suitable for single-crystal X-ray diffraction of the compound cyclometallated with phosphine ferrocene 10 were obtained by slow evaporation of a solution in acetone.
The compound crystallizes in the triclinic system, in the space group P‒1. The asymmetric unit is made up of a compound molecule and an acetone molecule (Figure 11). The two metalated ligand units lie in two almost parallel planes (with an angle between them of 2.82°).
The distance of the imine bond C7‒N1 (1295 Å) is shorter than in the case of the cyclometallated precursor, which agrees with the results observed in the displacement of the tension vibration bands υ (C=N).
It can also be observed how one of the phenyl rings of phosphine is perpendicular to the position where the H5 proton and one of the methoxy groups meet, which explains the effects observed in the NMR spectra on these signals (Figure 12).
On the other hand, cyclopentadienyl rings are placed in a nearly eclipsed conformation despite being in a higher energy arrangement.
The data obtained from the analysis of the X-ray diffraction of the Pd–Fe organometallic compound 10 are shown in Table 7.

4. Conclusions

The reaction of cyclometallated compounds with phosphine dppf gives rise to hetero-trinuclear cyclometallated compounds that contain two metallated thiosemicarbazone ligand units separated by diphosphine.
These compounds will be tested as possible sensors using cyclic voltammetry techniques.

Author Contributions

Conceptualization, P.M.-C.; methodology, P.M.-C. and M.R.-S.; software, P.M.-C.; validation, P.M.-C.; formal analysis, P.M.-C. and M.R.-S.; investigation, P.M.-C. and M.R.-S.; resources, M.T.P. and J.M.V.; data curation, P.M.-C.; writing—original draft preparation, P.M.-C.; writing—review and editing, P.M.-C.; visualization, P.M.-C.; supervision, J.M.V., J.M.O. and M.T.P.; project administration, P.M.-C. and M.R.-S.; funding acquisition, all authors. All authors have read and agreed to the published version of the manuscript.

Funding

The authors are grateful for the funding obtained from the Xunta de Galicia (Galicia, Spain) through the program: Competitive Reference Group GRC2019/14.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Shakya, B.; Yadav, P.N. Thiosemicarbazones as Potent Anticancer Agents and their Modes of Action, Mini-Rev. Med. Chem. 2020, 20, 638–661. [Google Scholar] [CrossRef]
  2. Hendricks, M.E.; Xu, X.; Boller, T.R.; Samples, M.E.; Johnson, R.A.; Nataro, C. Synthesis, characterization and electrochemistry of [Pd(PP)MeCl] compounds with 1,1′-bis(phosphino)ferrocene ligands. Polyhedron 2021, 199, 115104–115111. [Google Scholar] [CrossRef]
Figure 1. General retrosynthetic scheme of thiosemicarbazones.
Figure 1. General retrosynthetic scheme of thiosemicarbazones.
Chemproc 09 00005 g001
Figure 2. General structure of compounds 14.
Figure 2. General structure of compounds 14.
Chemproc 09 00005 g002
Figure 3. General synthesis scheme for ligands 14.
Figure 3. General synthesis scheme for ligands 14.
Chemproc 09 00005 g003
Figure 4. General synthetic scheme for the organometallic compounds (58).
Figure 4. General synthetic scheme for the organometallic compounds (58).
Chemproc 09 00005 g004
Figure 5. Expected Pd–Fe organometallic compounds.
Figure 5. Expected Pd–Fe organometallic compounds.
Chemproc 09 00005 g005
Figure 6. Obtained Pd–Fe organometallic compounds (912).
Figure 6. Obtained Pd–Fe organometallic compounds (912).
Chemproc 09 00005 g006
Figure 7. 1H NMR spectrum (250 MHz, CDCl3) of ligand 4.
Figure 7. 1H NMR spectrum (250 MHz, CDCl3) of ligand 4.
Chemproc 09 00005 g007
Figure 8. 1H NMR spectrum (250 MHz, CDCl3) of palladium organometallic compound 6.
Figure 8. 1H NMR spectrum (250 MHz, CDCl3) of palladium organometallic compound 6.
Chemproc 09 00005 g008
Figure 9. 1H NMR spectrum (400 MHz, CDCl3) of Pd–Fe organometallic compound 12.
Figure 9. 1H NMR spectrum (400 MHz, CDCl3) of Pd–Fe organometallic compound 12.
Chemproc 09 00005 g009
Figure 10. 31P-{1H}-NMR spectrum (400 MHz, CDCl3) of Pd–Fe organometallic compound 12.
Figure 10. 31P-{1H}-NMR spectrum (400 MHz, CDCl3) of Pd–Fe organometallic compound 12.
Chemproc 09 00005 g010
Figure 11. Crystal structure of compound 10 using a ball-and-stick model with standard CPK colors.
Figure 11. Crystal structure of compound 10 using a ball-and-stick model with standard CPK colors.
Chemproc 09 00005 g011
Figure 12. Interaction between Cp ring, H5 and the methoxy group.
Figure 12. Interaction between Cp ring, H5 and the methoxy group.
Chemproc 09 00005 g012
Table 1. Amounts of reagents used in the synthesis of the thiosemicarbazone ligands (14).
Table 1. Amounts of reagents used in the synthesis of the thiosemicarbazone ligands (14).
CompoundKetone (mmol)Thiosemicarbazide (mmol)R2
15.55.5H
25.55.5Me
35.55.5Et
45.55.5Ph
Table 2. Amounts of reagents used in the synthesis of the organometallic compounds (58).
Table 2. Amounts of reagents used in the synthesis of the organometallic compounds (58).
CompoundLigand AmountR2
51—0.67 mmolH
62—0.67 mmolMe
73—0.67 mmolEt
84—0.67 mmolPh
Table 3. Amounts of reagents used in the synthesis of the organometallic compounds (912).
Table 3. Amounts of reagents used in the synthesis of the organometallic compounds (912).
CompounddppfR2
90.20 mmolH
100.20 mmolMe
110.20 mmolEt
120.19 mmolPh
Table 4. 1H NMR data of ligands 14.
Table 4. 1H NMR data of ligands 14.
1H NMR Data
11H NMR (250 MHz, CDCl3) δ (ppm): 8.69 (s, 1H, NNH); 7.31 (m, 2H, NH, H6); 7.23 (d, 4J = 2.1 Hz, 1H, H2); 6.88 (d, 3J = 8.3 Hz, 1H, H5); 6.32 (s, 1H, NH); 3.93 (s, 3H, OMe); 3.92 (s, 3H, OMe); 2.28 (s, 3H, MeC=N).
21H NMR (250 MHz, CDCl3) δ (ppm): 8.61 (s, 1H, NNH); 7.57 (s, 1H, NHMe); 7.27 (d, 1H, 3J = 8.7 Hz, H6); 7.24 (d, 4J=2,1 Hz, 1H, H2); 6.89 (d, 1H, 3J=8,7 Hz, H5); 3.95 (s, 3H, OMe); 3.93 (s, 3H, OMe); 3.29 (d, 3J = 5.6 Hz, 3H, NHMe); 2.26 (s, 3H, MeC=N).
31H NMR (250 MHz, CDCl3) δ (ppm): 8.59 (s, 1H, NNH); 7.54 (m, 1H, NHEt); 7.23 (m, 1H, H6); 7.21 (d, 4J = 2.1 Hz, 1H, H2); 6,87 (d, 1H, 3J = 8.8 Hz, H5); 3.92 (s, 3H, OMe); 3.91 (s, 3H, OMe); 3.76 (m, 2H, NHCH2CH3); 2.25 (s, 3H, MeC=N); 1.29 (t, 3J = 7.3 Hz, 3H, NHCH2CH3).
41H NMR (250 MHz, CDCl3) δ (ppm): 9.34 (s, 1H, NHPh); 8.69 (s, 1H, NNH); 7.66 (d, 3J = 7.8 Hz, 2H, HaHa’); 7.38 (t, 3J = 7.8 Hz, 2H, HbHb’); 7.26 (m, 3H, H2H6Hc); 6.88 (d, 3J = 8.3 Hz, 1H, H5); 3.92 (s, 3H, OMe); 3.91 (s, 3H, OMe); 2.30 (s, 3H, MeC=N).
Table 5. 1H NMR data of palladium organometallic compounds (58).
Table 5. 1H NMR data of palladium organometallic compounds (58).
1H NMR Data
51H NMR (250 MHz, CDCl3) δ (ppm): 7.04 (s, 1H, H5); 6.23 (s, 1H, H2); 5.22 (s, 2H, NH2); 3.95 (s, 3H, OMe); 3.78 (s, 3H, OMe); 1.92 (s, 3H, MeC=N).
61H NMR (250 MHz, CDCl3) δ (ppm): 7.09 (s, 1H, H5); 6.27 (s, 1H, H2); 5,00 (m, 1H, NHMe); 3.97 (s, 3H, OMe); 3.81 (s, 3H, OMe); 2.96 (d, 3J = 4,9 Hz, 3H, NHMe); 1.93 (s, 3H, MeC=N).
71H NMR (250 MHz, CDCl3) δ (ppm): 7.08 (s, 1H, H5); 6.26 (s, 1H, H2); 5.03 (m, 1H, NHCH2CH3); 3.97 (s, 3H, OMe); 3.81 (s, 3H, OMe); 3.43 (m, 2H, NHCH2CH3); 1.95 (s, 3H, MeC=N); 1.22 (t, 3H, 3J = 7.2 Hz, NHCH2CH3).
81H NMR (250 MHz, CDCl3) δ (ppm): 7.52 (d, 3J = 7.6 Hz, 2H, HaHa’); 7.27 (t, 3J = 7.6 Hz, 2H, HbHb’); 7.01 (t, 3J = 7.6 Hz, 1H, Hc); 7.00 (s, 1H, NHPh); 6.94 (s, 1H, H5), 6.41 (s, 1H, H2); 3.86 (s, 3H, OMe); 3.51 (s, 3H, OMe); 1,91 (s, 3H, MeC=N).
Table 6. 1H NMR data of Pd–Fe organometallic compounds (912).
Table 6. 1H NMR data of Pd–Fe organometallic compounds (912).
1H NMR Data
91H NMR (400 MHz, dmso-d6) δ (ppm): 7.48 (m, 12H, m‒PPh2, p‒PPh2); 7.37 (m, 8H, o‒PPh2); 6.74 (s, 2H, H2); 6.55 (s, 4H, 2×NH2); 5.77 (d, 4JHP = 4.1 Hz, 2H, H5); 5.11 (s, 4H, Cp); 4.19 (s, 4H, Cp); 3.67 (s, 6H, 2×OMe); 2.80 (s, 6H, 2×OMe); 2.27 (s, 6H, 2×MeC=N).
31P‒{1H} NMR (400 MHz, dmso-d6) δ (ppm): 32.45 (s).
101H NMR (400 MHz, CDCl3) δ (ppm): 7.57 (m, 8H, m‒PPh2); 7.39 (t, 3J = 7.0 Hz, 4H, p‒PPh2); 7.30 (m, 8H, o‒PPh2); 6.69 (s, 2H, H2); 5.91 (d, 4JHP = 4.3 Hz, 2H, H5); 5.17 (s, 4H, Cp); 4.71 (s, 2H, 2×NHMe); 4.28 (s, 4H, Cp); 3.81 (s, 6H, 2×OMe); 2.97 (d, 3J = 4.9 Hz, 6H, 2×NHMe); 2.92 (s, 6H, 2×OMe); 2.40 (s, 6H, 2×MeC=N).
31P‒{1H} NMR (400 MHz, CDCl3) δ (ppm): 28.25 (s).
111H NMR (400 MHz, CDCl3) δ (ppm): 7.43 (m, 20H, PPh2); 6.66 (s, 2H, H2); 5.88 (s, 2H, H5); 5.15 (s, 4H, Cp); 4.68 (s, 2H, 2×NHCH2CH3); 4.25 (s, 4H, Cp); 3.78 (s, 6H, OMe); 3.37 (m, 4H, 2×NHCH2CH3); 2.90 (s, 6H, 2×OMe); 2.35 (s, 6H, 2×MeC=N); 1.14 (t, 6H, 3J = 6.8 Hz, 2×NHCH2CH3).
31P‒{1H} NMR (400 MHz, CDCl3) δ (ppm): 28.25 (s).
121H NMR (250 MHz, CDCl3) δ (ppm): 7.47 (m, 28H, PPh2, HaHa’HbHb’); 6.97 (t, 3J = 7.1 Hz, 2H, Hc); 6.75 (s, 2H, H2); 6.65 (s, 2H, 2×NHPh); 5.95 (d, 4JHP = 3.6 Hz, 2H, H5); 5.23 (s, 4H, Cp); 4.32 (s, 4H, Cp); 3.83 (s, 6H, 2×OMe); 2.93 (s, 6H, 2×OMe); 2.47 (s, 6H, 2×MeC=N).
31P‒{1H} NMR (400 MHz, CDCl3) δ (ppm): 28.22 (s).
Table 7. Crystallographic data of the Pd–Fe organometallic compound 10.
Table 7. Crystallographic data of the Pd–Fe organometallic compound 10.
Compound10
Empirical formulaC58H58FeN6O4P2Pd2S2 · C3H6O
Formula weight1355.89
Temperature100 (2) K
Wavelength0.71073 Å
Crystal systemTriclinic
Space groupP‒1
Unit cell dimensionsa = 11,148 (5)Å; α = 86,251 (5)°
b = 12,652 (5)Å; β = 84,791 (5)°
c = 20,736 (5)Å; γ = 78,360 (5)°
Volume2849 (18)Å3
Z2
Calculated density1.580 Mg/m3
Absorption coefficient1.061 mm−1
F(000)1384
Crystal size0.22 × 0.15 × 0.04 mm3
Theta range for data collection0.987–26,373°
Limiting indexes−13 ≤ h ≤ 13
−15 ≤ k ≤ 15
−25 ≤ l ≤ 25
Reflections collected87,669
Reflections unique11,617 [R(int) = 0.0444]
Data/restraints/parameters11,617/0/888
Goodness-of-fit on F21.028
Final R indexes [I > 2sigma(I)]R1 = 0.0273; wR2 = 0.0588
R indexes (all data)R1 = 0.0405; wR2 = 0.0632
Largest diff. peak and hole0.675 y − 0.662 e/Å3
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Munín-Cruz, P.; Rúa-Sueiro, M.; Ortigueira, J.M.; Pereira, M.T.; Vila, J.M. Structural Study of a Pd–Fe Hetero-Trinuclear Compound. Chem. Proc. 2022, 9, 5. https://doi.org/10.3390/IOCC_2022-12145

AMA Style

Munín-Cruz P, Rúa-Sueiro M, Ortigueira JM, Pereira MT, Vila JM. Structural Study of a Pd–Fe Hetero-Trinuclear Compound. Chemistry Proceedings. 2022; 9(1):5. https://doi.org/10.3390/IOCC_2022-12145

Chicago/Turabian Style

Munín-Cruz, Paula, Marcos Rúa-Sueiro, Juan M. Ortigueira, María Teresa Pereira, and José M. Vila. 2022. "Structural Study of a Pd–Fe Hetero-Trinuclear Compound" Chemistry Proceedings 9, no. 1: 5. https://doi.org/10.3390/IOCC_2022-12145

Article Metrics

Back to TopTop